BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9731042)

  • 1. Activation of p38 MAP kinase and JNK but not ERK is required for erythropoietin-induced erythroid differentiation.
    Nagata Y; Takahashi N; Davis RJ; Todokoro K
    Blood; 1998 Sep; 92(6):1859-69. PubMed ID: 9731042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Requirement of activation of JNK and p38 for environmental stress-induced erythroid differentiation and apoptosis and of inhibition of ERK for apoptosis.
    Nagata Y; Todokoro K
    Blood; 1999 Aug; 94(3):853-63. PubMed ID: 10419875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct roles of JNKs/p38 MAP kinase and ERKs in apoptosis and survival of HCD-57 cells induced by withdrawal or addition of erythropoietin.
    Shan R; Price JO; Gaarde WA; Monia BP; Krantz SB; Zhao ZJ
    Blood; 1999 Dec; 94(12):4067-76. PubMed ID: 10590051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JNK and p38 are activated by erythropoietin (EPO) but are not induced in apoptosis following EPO withdrawal in EPO-dependent HCD57 cells.
    Jacobs-Helber SM; Ryan JJ; Sawyer ST
    Blood; 2000 Aug; 96(3):933-40. PubMed ID: 10910907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of p38 MAP kinase pathway by erythropoietin and interleukin-3.
    Nagata Y; Moriguchi T; Nishida E; Todokoro K
    Blood; 1997 Aug; 90(3):929-34. PubMed ID: 9242520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of JNK signaling pathway by erythropoietin, thrombopoietin, and interleukin-3.
    Nagata Y; Nishida E; Todokoro K
    Blood; 1997 Apr; 89(8):2664-9. PubMed ID: 9108383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Butyrate-induced erythroid differentiation of human K562 leukemia cells involves inhibition of ERK and activation of p38 MAP kinase pathways.
    Witt O; Sand K; Pekrun A
    Blood; 2000 Apr; 95(7):2391-6. PubMed ID: 10733512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor.
    Sutherland CL; Heath AW; Pelech SL; Young PR; Gold MR
    J Immunol; 1996 Oct; 157(8):3381-90. PubMed ID: 8871635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematopoietic cell phosphatase negatively regulates erythropoietin-induced hemoglobinization in erythroleukemic SKT6 cells.
    Sharlow ER; Pacifici R; Crouse J; Batac J; Todokoro K; Wojchowski DM
    Blood; 1997 Sep; 90(6):2175-87. PubMed ID: 9310468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A functional role of mitogen-activated protein kinases, erk1 and erk2, in the differentiation of a human leukemia cell line, UT-7/GM: a possible key factor for cell fate determination toward erythroid and megakaryocytic lineages.
    Uchida M; Kirito K; Shimizu R; Miura Y; Ozawa K; Komatsu N
    Int J Hematol; 2001 Jan; 73(1):78-83. PubMed ID: 11372759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine-specific activation of distinct mitogen-activated protein kinase subtype cascades in human neutrophils stimulated by granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and tumor necrosis factor-alpha.
    Suzuki K; Hino M; Hato F; Tatsumi N; Kitagawa S
    Blood; 1999 Jan; 93(1):341-9. PubMed ID: 9864179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium.
    Chuang SM; Wang IC; Yang JL
    Carcinogenesis; 2000 Jul; 21(7):1423-32. PubMed ID: 10874022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of hematopoietic progenitor kinase-1 by erythropoietin.
    Nagata Y; Kiefer F; Watanabe T; Todokoro K
    Blood; 1999 May; 93(10):3347-54. PubMed ID: 10233887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dual function for p38 MAP kinase in hematopoietic cells: involvement in apoptosis and cell activation.
    Birkenkamp KU; Dokter WH; Esselink MT; Jonk LJ; Kruijer W; Vellenga E
    Leukemia; 1999 Jul; 13(7):1037-45. PubMed ID: 10400419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of erythroid differentiation by inhibition of Ras/ERK pathway in a friend murine leukemia cell line.
    Matsuzaki T; Aisaki Ki; Yamamura Y; Noda M; Ikawa Y
    Oncogene; 2000 Mar; 19(12):1500-8. PubMed ID: 10734309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis.
    Xia Z; Dickens M; Raingeaud J; Davis RJ; Greenberg ME
    Science; 1995 Nov; 270(5240):1326-31. PubMed ID: 7481820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A human homolog of the yeast Ssk2/Ssk22 MAP kinase kinase kinases, MTK1, mediates stress-induced activation of the p38 and JNK pathways.
    Takekawa M; Posas F; Saito H
    EMBO J; 1997 Aug; 16(16):4973-82. PubMed ID: 9305639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of multiple mitogen-activated protein kinase sub-families by oxidative stress and phosphorylation of the small heat shock protein, HSP25/27, in neonatal ventricular myocytes.
    Clerk A; Michael A; Sugden PH
    Biochem J; 1998 Aug; 333 ( Pt 3)(Pt 3):581-9. PubMed ID: 9677316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-induced proliferative response of vascular adventitial fibroblasts is dependent on g protein-mediated activation of mitogen-activated protein kinases.
    Das M; Bouchey DM; Moore MJ; Hopkins DC; Nemenoff RA; Stenmark KR
    J Biol Chem; 2001 May; 276(19):15631-40. PubMed ID: 11278727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin enhancement of rat pancreatic tumor cell proliferation requires the activation of ERK and JNK signals.
    Bose C; Udupa KB
    Am J Physiol Cell Physiol; 2008 Aug; 295(2):C394-405. PubMed ID: 18550701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.